Wexford Capital’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,400
Closed -$350K 184
2017
Q2
$350K Buy
+4,400
New +$350K 0.03% 138
2016
Q3
Sell
-30,396
Closed -$916K 180
2016
Q2
$916K Hold
30,396
0.16% 76
2016
Q1
$974K Buy
+30,396
New +$974K 0.19% 78